Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Cancer. 2018 Jan 16;124(7):1374–1382. doi: 10.1002/cncr.31218

Figure 1.

Figure 1

Figure 1

Figure 1a. Best Target Response in Patients

Waterfall plot depicting best target response in all patients on study. Seven patients had a response and 8 patients had stable disease. Individuals with BRCA mutations overwhelmingly had a response compared to those without mutations. The patient with unknown BRCA status had a 21.4% reduction per RECIST 1.1.

Figure 1b. Overall Survival and Treatment Duration

Swimmers plot depicting overall survival and indicating treatment duration. Note that BRCA+ patients remained on treatment for a longer duration and had more favorable survival. The patient with unknown BRCA status was on treatment for 8.8 months and had an OS of 12.3 months.